Skip to Main Content
An official website of the United States government

AI Enhanced Triage in Lung Cancer Screening

Principal Investigator

Name
Gerardo Hermosillo Valadez

Degrees
Ph.D.

Institution
Siemens Medical Solutions USA

Position Title
Research and Technology Manager

Email
gerardo.hermosillovaladez@siemens-healthineers.com

About this CDAS Project

Study
NLST (Learn more about this study)

Project ID
NLST-1314

Initial CDAS Request Approval
Sep 5, 2024

Title
AI Enhanced Triage in Lung Cancer Screening

Summary
Evaluate existing AI technologies for their accuracy in detecting, measuring, and classifying pulmonary nodules, as well as estimating malignancy risk and identifying incidental findings. Explore methods to prioritize allocation of resources to significant findings based on patient history and priors.

Aims

1 Quantify False Positives and Malignancy Risk Scores: Determine the frequency and types of false positives and assess the accuracy of AI-based malignancy risk scores.

2 Evaluate AI-Driven Nodule Measurement and Tracking: Measure the accuracy and reliability of AI systems in the automatic measurement and longitudinal tracking of pulmonary nodules.

3 Improve Triage Systems for Non-Actionable Patients: Assess the negative predictive value and specificity of AI-based triage systems designed to rule out non-actionable patients.

Collaborators

Abdishektaei, Arya
Farhand, Sepehr
Yerebakan, Halid
Guo, Xueqi
Wolf, Matthias
Peng, Zhigang
Shinagawa, Yoshihisa
Ranganath, Mahesh,
Iyer, Kritika
Allen-Raffl, Simon